ARTICLE SUMMARY:
Start-up Injectsense has an ultraminiature, MEMS-based sensor technology for remote patient monitoring that can be injected into the eye or other tissues, or integrated with an implantable device, and can be configured to measure a variety of parameters.
Remote patient monitoring (RPM) is receiving a lot of attention at the moment due to the COVID-19 pandemic and the search for safer, cost-effective ways to remotely monitor patients—both those with chronic and acute conditions—from their homes or at the hospital bedside. (See “Remote Patient Monitoring Enters a New Era,” MedTech Strategist, June 22, 2020.) A variety of technologies and form factors are being developed for RPM, ranging from wrist-worn wearables and body-worn biostickers to injectable/implantable sensors, and sensors that integrate with a smartphone.
